UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007552
Receipt No. R000008920
Scientific Title A randomized controlled trial of cognitive behavior therapy as an adjunct to usualcare for social anxiety disorder refractory to initial SSRI treatment
Date of disclosure of the study information 2012/03/30
Last modified on 2017/11/15 16:37:48

No. Disposal Last modified on Item of update
1 Insert 2012/03/22 16:00:32
2 Update 2012/03/29 14:58:18 Date of disclosure of the study information
3 Update 2012/03/29 15:05:50 Public title
4 Update 2012/03/29 15:07:13 Interventions/Control_1
Interventions/Control_1
5 Update 2012/06/29 12:14:11 Anticipated trial start date
6 Update 2012/06/29 12:16:06 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
7 Update 2012/06/29 12:16:39 Recruitment status
8 Update 2012/09/26 04:46:27 Key inclusion criteria
9 Update 2012/09/26 04:46:48 Key inclusion criteria
Target sample size
10 Update 2013/05/04 04:18:45 Email
11 Update 2013/09/23 12:48:47 Email
12 Update 2013/09/23 12:49:46 Recruitment status
13 Update 2014/03/25 10:26:32 Recruitment status
Last follow-up date
URL releasing protocol
14 Update 2014/06/19 16:13:19 Key inclusion criteria
15 Update 2014/06/19 16:15:42 Key secondary outcomes
Key secondary outcomes
16 Update 2015/03/05 11:13:35 Key secondary outcomes
Key secondary outcomes
17 Update 2015/12/15 10:37:10 Narrative objectives1
Basic objectives2
Basic objectives -Others
Basic objectives -Others
Trial characteristics_2
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
18 Update 2015/12/15 10:44:20 Results
Results
Other related information
Other related information
19 Update 2016/02/08 13:37:00 Results
Other related information
20 Update 2016/06/14 10:58:17 Name of primary sponsor
Organization
Category of Funding Organization
21 Update 2016/06/14 10:59:11 Publication of results
URL related to results and publications
22 Update 2017/11/15 16:37:48 Key secondary outcomes


Contact us.